|
MFAP3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.73750000000062E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.060260E-03 |
| Normal-vs-Stage2 |
7.341000E-03 |
| Normal-vs-Stage3 |
1.08070000004457E-06 |
| Normal-vs-Stage4 |
1.56790000005458E-06 |
| Stage1-vs-Stage2 |
9.350200E-01 |
| Stage1-vs-Stage3 |
1.811880E-02 |
| Stage1-vs-Stage4 |
1.300250E-02 |
| Stage2-vs-Stage3 |
1.176400E-01 |
| Stage2-vs-Stage4 |
8.343900E-02 |
| Stage3-vs-Stage4 |
7.517800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.64629999999511E-05 |
| Normal-vs-AfricanAmerican |
1.754020E-02 |
| Normal-vs-Asian |
7.656400E-03 |
| Caucasian-vs-AfricanAmerican |
7.736800E-01 |
| Caucasian-vs-Asian |
5.924600E-01 |
| AfricanAmerican-vs-Asian |
9.193800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.32749999999893E-05 |
| Normal-vs-Female |
1.197020E-04 |
| Male-vs-Female |
3.180000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.878900E-03 |
| Normal-vs-Age(41-60Yrs) |
2.43789999998523E-06 |
| Normal-vs-Age(61-80Yrs) |
1.75780999999153E-05 |
| Normal-vs-Age(81-100Yrs) |
7.445900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.156400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.447800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.611400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.968200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.736800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.672800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.622500E-03 |
| Classical-VS-Follicular |
4.119600E-02 |
| Classical-VS-Other |
1.154020E-01 |
| Classical-VS-Normal |
1.843610E-03 |
| Tall-VS-Follicular |
1.536190E-01 |
| Tall-VS-Other |
8.867400E-01 |
| Tall-VS-Normal |
1.8341999999949E-06 |
| Follicular-VS-Other |
3.765600E-01 |
| Follicular-VS-Normal |
4.34690000000737E-05 |
| Other-VS-Normal |
5.860800E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.40929999999673E-05 |
| Normal-vs-N1 |
1.158900E-04 |
| N0-vs-N1 |
4.402600E-01 |
|
|
